Berry Gene (000710.SZ) released its first quarter performance report, showing a net loss of 19.7382 million yuan attributable to shareholders.

The Zhitong Finance and Economics APP reports that Berry Genomics (000710.SZ) has released its first quarter report for 2026. In the first quarter, the company achieved operating income of 210 million yuan, a year-on-year decrease of 3.46%. The net loss attributable to shareholders of the listed company was 19.7382 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 19.7073 million yuan.